Eton Pharmaceuticals Inc
ETON16.900USD
-2.240-11.70%
收盘 11/07, 16:00（美东）报价延迟15分钟
453.22M总市值
亏损市盈率 TTM
关于 Eton Pharmaceuticals Inc 公司
Eton Pharmaceuticals, Inc. 是一家专注于开发和商业化罕见病治疗的制药公司。该公司有六种商业罕见病产品：INCRELEX、ALKINDI SPRINKLE、PKU GOLIKE、卡谷氨酸、无水甜菜碱和尼替西农。INCRELEX 是一种生物制品，用于治疗 2 岁及以上患有严重原发性胰岛素样生长因子 1 缺乏症 (SPIGFD) 的儿科患者。ALKINDI SPRINKLE 用于治疗儿童肾上腺皮质功能不全。卡谷氨酸用于治疗因 N-乙酰谷氨酸合酶 (NAGS) 缺乏引起的高氨血症。无水甜菜碱用于治疗同型胱氨酸尿症。尼替西农用于治疗 1 型遗传性酪氨酸血症 (HT-1)。PKU GOLIKE 是一种针对苯丙酮尿症 (PKU) 患者的医疗配方。其产品 Galzin 已获得 FDA 批准用于治疗极为罕见的威尔逊氏病代谢疾病。
Eton Pharmaceuticals Inc简介
公司代码ETON
公司名称Eton Pharmaceuticals Inc
上市日期Nov 09, 2018
CEOMr. Sean E. Brynjelsen
员工数量31
证券类型Ordinary Share
年结日Nov 09
公司地址21925 W Field Pkwy Ste 235
城市DEER PARK
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编60010-7278
电话18477877361
网址https://etonpharma.com/
公司代码ETON
上市日期Nov 09, 2018
CEOMr. Sean E. Brynjelsen
Eton Pharmaceuticals Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Sean E. Brynjelsen
Mr. Sean E. Brynjelsen
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
864.94K
-19.54%
Mr. Charles J. (Chuck) Casamento
Mr. Charles J. (Chuck) Casamento
Independent Director
Independent Director
93.42K
--
Mr. Paul V. Maier
Mr. Paul V. Maier
Independent Director
Independent Director
84.75K
--
Dr. Norbert G. Riedel, Ph.D.
Dr. Norbert G. Riedel, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
84.75K
-54.72%
Mr. James R. Gruber
Mr. James R. Gruber
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
21.71K
-34.20%
Ms. Ipek Erdogan-Trinkaus
Ms. Ipek Erdogan-Trinkaus
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. David C. Krempa
Mr. David C. Krempa
Chief Business Officer
Chief Business Officer
--
--
Ms. Jennifer (Jenn) Adams
Ms. Jennifer (Jenn) Adams
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Sean E. Brynjelsen
Mr. Sean E. Brynjelsen
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
864.94K
-19.54%
Mr. Charles J. (Chuck) Casamento
Mr. Charles J. (Chuck) Casamento
Independent Director
Independent Director
93.42K
--
Mr. Paul V. Maier
Mr. Paul V. Maier
Independent Director
Independent Director
84.75K
--
Dr. Norbert G. Riedel, Ph.D.
Dr. Norbert G. Riedel, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
84.75K
-54.72%
Mr. James R. Gruber
Mr. James R. Gruber
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
21.71K
-34.20%
Ms. Ipek Erdogan-Trinkaus
Ms. Ipek Erdogan-Trinkaus
Chief Commercial Officer
Chief Commercial Officer
--
--
收入明细
FY2025Q2
FY2025Q1
FY2024
暂无数据
地区USD
名称
营收
占比
United States
18.93M
0.00%
业务
地区
暂无数据
股东统计
更新时间: 8月23日 周六
更新时间: 8月23日 周六
持股股东
股东类型
持股股东
持股股东
占比
Opaleye Management Inc.
10.66%
EcoR1 Capital, LLC
7.57%
BlackRock Institutional Trust Company, N.A.
5.22%
The Vanguard Group, Inc.
5.01%
Nantahala Capital Management, LLC
4.38%
其他
67.15%
持股股东
持股股东
占比
Opaleye Management Inc.
10.66%
EcoR1 Capital, LLC
7.57%
BlackRock Institutional Trust Company, N.A.
5.22%
The Vanguard Group, Inc.
5.01%
Nantahala Capital Management, LLC
4.38%
其他
67.15%
股东类型
持股股东
占比
Hedge Fund
21.77%
Investment Advisor/Hedge Fund
19.48%
Investment Advisor
17.48%
Individual Investor
4.30%
Research Firm
3.05%
Pension Fund
0.37%
Bank and Trust
0.10%
Insurance Company
0.04%
其他
33.41%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
196
16.81M
62.69%
+511.79K
2025Q2
158
16.03M
59.76%
-1.46M
2025Q1
154
15.73M
58.88%
-1.49M
2024Q4
125
14.61M
54.85%
+562.47K
2024Q3
98
10.99M
42.37%
-1.69M
2024Q2
94
9.67M
37.40%
-2.32M
2024Q1
94
10.57M
41.25%
-1.37M
2023Q4
96
10.49M
40.94%
-1.03M
2023Q3
99
10.24M
39.99%
-325.57K
2023Q2
102
9.33M
36.53%
-1.39M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Opaleye Management Inc.
2.86M
10.66%
+7.93K
+0.28%
Jun 30, 2025
EcoR1 Capital, LLC
2.03M
7.57%
+91.26K
+4.71%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.40M
5.22%
+1.08M
+334.29%
Jun 30, 2025
The Vanguard Group, Inc.
1.31M
4.89%
+211.21K
+19.18%
Jun 30, 2025
Nantahala Capital Management, LLC
1.18M
4.38%
--
--
Jun 30, 2025
Brynjelsen (Sean E)
864.94K
3.23%
-210.00K
-19.54%
Jun 05, 2025
Geode Capital Management, L.L.C.
592.87K
2.21%
+294.62K
+98.78%
Jun 30, 2025
Divisadero Street Capital Management, LP
497.72K
1.86%
+497.72K
--
Jun 30, 2025
Westside Investment Management, LLC
472.79K
1.76%
-20.86K
-4.23%
Jun 30, 2025
Renaissance Technologies LLC
405.90K
1.51%
+131.90K
+48.14%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月6日 周四
更新时间: 11月6日 周四
机构名称
占比
First Trust Active Factor Small Cap ETF
0.15%
iShares Micro-Cap ETF
0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.09%
Vanguard US Momentum Factor ETF
0.08%
iShares Russell 2000 Growth ETF
0.03%
iShares Russell 2000 ETF
0.02%
ProShares Hedge Replication ETF
0.02%
Global X Russell 2000 ETF
0.02%
Proshares Ultra Russell 2000
0.02%
ProShares UltraPro Russell2000
0.02%
查看更多
First Trust Active Factor Small Cap ETF
占比0.15%
iShares Micro-Cap ETF
占比0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.09%
Vanguard US Momentum Factor ETF
占比0.08%
iShares Russell 2000 Growth ETF
占比0.03%
iShares Russell 2000 ETF
占比0.02%
ProShares Hedge Replication ETF
占比0.02%
Global X Russell 2000 ETF
占比0.02%
Proshares Ultra Russell 2000
占比0.02%
ProShares UltraPro Russell2000
占比0.02%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
